Skip to content

Clinical trials

Leiomyosarcoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20051
20062
20071
20111
20121
20151
20161
20172
20213
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC8
Advenchen Laboratories, LLC1
Eli Lilly and Company1
Epkin1
GlaxoSmithKline1
Grupo Espanol de Investigacion en Sarcomas1
PTC Therapeutics1
PharmaMar1
Pierre Fabre Medicament1
Royal Marsden NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma21
Sarcoma17
Liposarcoma14
Hemangiosarcoma12
Histiocytoma, Malignant Fibrous12
Sarcoma, Synovial11
Fibrosarcoma10
Neurofibrosarcoma8
Sarcoma, Alveolar Soft Part6
Rhabdomyosarcoma5

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.